Drawing for GENOVAX

USPTO serial 76215730

GENOVAX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DEFORD, JEFFREY S
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with GENOVAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert J. Patch

Mark Lebow YOUNG & THOMPSON209 Madison StreetSuite 500Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for use in gene and gene therapy; media for bacteriological cultures; culture media comprising amino acids, viral genomes, plasmids and nucleic acid vectors; cells for medical, pharmaceutical, veterinary or clinical use, namely for use in gene therapy and cell therapyACTIVE—
042Medical, biomedical, chemical, pharmaceutical or veterinary research and laboratory research in the field of gene therapy; licensing of intellectual property rights; quality control for others; research and development of new products or third parties, in the files of gene therapy and cell therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 15, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 28, 2003CFITCASE FILE IN TICRS—
Jan 31, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 8, 2002DOCKASSIGNED TO EXAMINER—
Jul 30, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 15, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 20021.BDSec. 1(B) CLAIM DELETED—
Jan 14, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance